(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.42%) $0.928
(-1.07%) $10.87
(-0.03%) $0.798
(0.35%) $91.45
0.34% £ 29.90
Live Chart Being Loaded With Signals
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally...
Stats | |
---|---|
Tagesvolumen | 131 089 |
Durchschnittsvolumen | 312 504 |
Marktkapitalisierung | 135.67M |
EPS | £0 ( 2024-03-25 ) |
Last Dividend | £1.200 ( 2022-11-02 ) |
Next Dividend | £0 ( N/A ) |
P/E | 29.90 |
ATR14 | £0.767 (2.57%) |
EKF Diagnostics Holdings Korrelation
10 Am meisten positiv korreliert | |
---|---|
MPL.L | 0.932 |
PDL.L | 0.924 |
TPX.L | 0.923 |
OMIP.L | 0.916 |
RDT.L | 0.913 |
SCLP.L | 0.913 |
3SNV.L | 0.909 |
TBLD.L | 0.909 |
3SUB.L | 0.906 |
DSW.L | 0.902 |
10 Am meisten negativ korreliert | |
---|---|
AEXG.L | -0.959 |
EMR.L | -0.958 |
CFX.L | -0.957 |
INSE.L | -0.949 |
SPEC.L | -0.939 |
VAST.L | -0.939 |
SKL.L | -0.938 |
NWT.L | -0.934 |
IPF.L | -0.932 |
GRA.L | -0.926 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
EKF Diagnostics Holdings Finanzdaten
Annual | 2023 |
Umsatz: | £52.61M |
Bruttogewinn: | £24.44M (46.45 %) |
EPS: | £0.00520 |
FY | 2023 |
Umsatz: | £52.61M |
Bruttogewinn: | £24.44M (46.45 %) |
EPS: | £0.00520 |
FY | 2022 |
Umsatz: | £66.64M |
Bruttogewinn: | £24.04M (36.07 %) |
EPS: | £-0.0209 |
FY | 2021 |
Umsatz: | £81.84M |
Bruttogewinn: | £39.37M (48.10 %) |
EPS: | £0.0347 |
Financial Reports:
No articles found.
EKF Diagnostics Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£1.200 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.000 | 2020-11-04 |
Last Dividend | £1.200 | 2022-11-02 |
Next Dividend | £0 | N/A |
Payout Date | 2022-12-01 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | £3.30 | -- |
Avg. Dividend % Per Year | 0.73% | -- |
Score | 3.09 | -- |
Div. Sustainability Score | 9.77 | |
Div.Growth Potential Score | 5.27 | |
Div. Directional Score | 7.52 | -- |
Year | Amount | Yield |
---|---|---|
2020 | £1.000 | 2.98% |
2021 | £1.100 | 1.62% |
2022 | £1.200 | 1.58% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TFGS.L | No Dividend Player | 2023-08-02 | Annually | 7 | 0.01% | |
LBOW.L | Dividend Royal | 2023-08-17 | Bi-Monthly | 12 | 15.93% | |
CHG.L | Dividend Knight | 2023-08-17 | Semi-Annually | 32 | 1.19% | |
RESI.L | Dividend Knight | 2023-08-10 | Quarterly | 7 | 3.27% | |
GRP.L | Dividend Knight | 2023-08-10 | Quarterly | 7 | 3.24% | |
ARBB.L | Dividend Knight | 2023-08-24 | Annually | 32 | 3.06% | |
UJO.L | Dividend Knight | 2023-07-06 | Annually | 3 | 1.30% | |
MGP.L | Dividend Knight | 2023-06-22 | Annually | 8 | 1.00% | |
CTO.L | Dividend King | 2023-08-31 | Semi-Annually | 32 | 2.55% | |
SDR.L | Dividend King | 2023-08-17 | Semi-Annually | 32 | 2.67% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0447 | 1.500 | 9.11 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0291 | 1.200 | 9.03 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0358 | 1.500 | -0.713 | -1.070 | [0.1 - 1] |
payoutRatioTTM | 2.32 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.69 | 0.800 | 1.545 | 1.236 | [1 - 3] |
quickRatioTTM | 1.768 | 0.800 | 4.31 | 3.45 | [0.8 - 2.5] |
cashRatioTTM | 0.814 | 1.500 | 6.59 | 9.89 | [0.2 - 2] |
debtRatioTTM | 0.0507 | -1.500 | 9.16 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 63.41 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0139 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00146 | 2.00 | -0.000732 | -0.00146 | [0 - 20] |
debtEquityRatioTTM | 0.0611 | -1.500 | 9.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.464 | 1.000 | 5.59 | 5.59 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0904 | 1.000 | -0.192 | -0.192 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.540 | 1.000 | 2.56 | 2.56 | [0.2 - 2] |
assetTurnoverTTM | 0.651 | 0.800 | 9.00 | 7.20 | [0.5 - 2] |
Total Score | 9.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.30 | 1.000 | 4.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0358 | 2.50 | -0.458 | -1.070 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00146 | 2.00 | -0.000488 | -0.00146 | [0 - 30] |
dividendYielPercentageTTM | 4.04 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0139 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.32 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 57.30 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.50 | 0 | [0.1 - 0.5] |
Total Score | 5.27 |
EKF Diagnostics Holdings
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.